99 related articles for article (PubMed ID: 10395747)
61. A new human peptide deformylase inhibitable by actinonin.
Lee MD; Antczak C; Li Y; Sirotnak FM; Bornmann WG; Scheinberg DA
Biochem Biophys Res Commun; 2003 Dec; 312(2):309-15. PubMed ID: 14637138
[TBL] [Abstract][Full Text] [Related]
62. Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.
Che X; Hu J; Wang L; Zhu Z; Xu Q; Lv J; Fu Z; Sun Y; Sun J; Lin G; Lu R; Yao Z
Mol Cell Biochem; 2011 Nov; 357(1-2):47-54. PubMed ID: 21603885
[TBL] [Abstract][Full Text] [Related]
63. Organellar peptide deformylases: universality of the N-terminal methionine cleavage mechanism.
Giglione C; Meinnel T
Trends Plant Sci; 2001 Dec; 6(12):566-72. PubMed ID: 11738381
[TBL] [Abstract][Full Text] [Related]
64. Identification of crucial amino acids of bacterial Peptide deformylases affecting enzymatic activity in response to oxidative stress.
Kumar S; Kanudia P; Karthikeyan S; Chakraborti PK
J Bacteriol; 2014 Jan; 196(1):90-9. PubMed ID: 24142250
[TBL] [Abstract][Full Text] [Related]
65. Oxygen-mediated inactivation of peptide deformylase.
Rajagopalan PT; Pei D
J Biol Chem; 1998 Aug; 273(35):22305-10. PubMed ID: 9712848
[TBL] [Abstract][Full Text] [Related]
66. Distinctive features of the two classes of eukaryotic peptide deformylases.
Serero A; Giglione C; Meinnel T
J Mol Biol; 2001 Dec; 314(4):695-708. PubMed ID: 11733990
[TBL] [Abstract][Full Text] [Related]
67. Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents.
Giglione C; Pierre M; Meinnel T
Mol Microbiol; 2000 Jun; 36(6):1197-205. PubMed ID: 10931273
[TBL] [Abstract][Full Text] [Related]
68. Peptide-gap inhibitors: I. Competitive inhibition of aminopeptidase M by a hydrolytically resistant dipeptide analogue of glycylleucine.
Fok KF; Yankeelov JA
Biochem Biophys Res Commun; 1977 Jan; 74(1):273-8. PubMed ID: 836284
[No Abstract] [Full Text] [Related]
69. Model complexes of the active site in peptide deformylase: a new family of mononuclear N2S-M(II) complexes.
Chang S; Karambelkar VV; diTargiani RC; Goldberg DP
Inorg Chem; 2001 Jan; 40(2):194-5. PubMed ID: 11170522
[No Abstract] [Full Text] [Related]
70. Peptide deformylase as an emerging target for antiparasitic agents.
Giglione C; Meinnel T
Expert Opin Ther Targets; 2001 Feb; 5(1):41-57. PubMed ID: 15992167
[TBL] [Abstract][Full Text] [Related]
71. Self-assembling cytotoxins.
Rideout D
Science; 1986 Aug; 233(4763):561-3. PubMed ID: 3523757
[TBL] [Abstract][Full Text] [Related]
72. Anti-vibriosis bioactive molecules from Arctic Penicillium sp. Z2230.
Guo J; Yang J; Wang P; Guo B; Li H; Zhang D; An F; Gao S
Bioresour Bioprocess; 2023 Feb; 10(1):11. PubMed ID: 38647601
[TBL] [Abstract][Full Text] [Related]
73. Targeting Metalloenzymes for Therapeutic Intervention.
Chen AY; Adamek RN; Dick BL; Credille CV; Morrison CN; Cohen SM
Chem Rev; 2019 Jan; 119(2):1323-1455. PubMed ID: 30192523
[TBL] [Abstract][Full Text] [Related]
74. Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
Lee MD; She Y; Soskis MJ; Borella CP; Gardner JR; Hayes PA; Dy BM; Heaney ML; Philips MR; Bornmann WG; Sirotnak FM; Scheinberg DA
J Clin Invest; 2004 Oct; 114(8):1107-16. PubMed ID: 15489958
[TBL] [Abstract][Full Text] [Related]
75. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.
Fu H; Dahlgren C; Bylund J
Antimicrob Agents Chemother; 2003 Aug; 47(8):2545-50. PubMed ID: 12878517
[TBL] [Abstract][Full Text] [Related]
76. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.
Hackbarth CJ; Chen DZ; Lewis JG; Clark K; Mangold JB; Cramer JA; Margolis PS; Wang W; Koehn J; Wu C; Lopez S; Withers G; Gu H; Dunn E; Kulathila R; Pan SH; Porter WL; Jacobs J; Trias J; Patel DV; Weidmann B; White RJ; Yuan Z
Antimicrob Agents Chemother; 2002 Sep; 46(9):2752-64. PubMed ID: 12183225
[TBL] [Abstract][Full Text] [Related]
77. Eukaryotic peptide deformylases. Nuclear-encoded and chloroplast-targeted enzymes in Arabidopsis.
Dirk LM; Williams MA; Houtz RL
Plant Physiol; 2001 Sep; 127(1):97-107. PubMed ID: 11553738
[TBL] [Abstract][Full Text] [Related]
78. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
[TBL] [Abstract][Full Text] [Related]
79. Peptide aldehyde inhibitors of bacterial peptide deformylases.
Durand DJ; Gordon Green B; O'Connell JF; Grant SK
Arch Biochem Biophys; 1999 Jul; 367(2):297-302. PubMed ID: 10395747
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and antibacterial activity of peptide deformylase inhibitors.
Huntington KM; Yi T; Wei Y; Pei D
Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
